Sanara MedTech (SMTI) Cash from Investing Activities (2010 - 2026)
Sanara MedTech (SMTI) posted Cash from Investing Activities of -$43772.0 for Q1 2026, up 98.21% on a QoQ basis from -$2.4 million in Q4 2025, and up 99.15% year-over-year from -$21978.9 in Q1 2025.
Sanara MedTech (SMTI) Cash from Investing Activities (2010 - 2026) Analysis & Trends
Sanara MedTech's Cash from Investing Activities history runs 15 years deep, the most recent figure standing at -$43772.0 for Q1 2026.
- Quarterly Cash from Investing Activities rose 99.15% year-over-year to -$43772.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$9.8 million (up 16.1% YoY) and the FY2025 annual result came in at -$15.0 million, down 126.48% from the prior year.
- Cash from Investing Activities was -$43772.0 for Q1 2026 at Sanara MedTech, up from -$2.4 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at -$12945.0 in Q2 2023 and bottomed at -$10.1 million in Q3 2023.
- A 5-year average of -$2.1 million and a median of -$376954.0 in 2022 frame the typical range for Cash from Investing Activities.
- Annual changes were most pronounced in 2023 — Cash from Investing Activities soared 99.38% — and 2025, when it plunged 7769.97%.
- Sanara MedTech's Cash from Investing Activities stood at -$376954.0 in 2022, then soared by 85.6% to -$54276.0 in 2023, then slumped by 139.51% to -$129994.0 in 2024, then plunged by 1781.07% to -$2.4 million in 2025, then jumped by 98.21% to -$43772.0 in 2026.
- Business Quant data shows SMTI's Cash from Investing Activities at -$43772.0 in Q1 2026, -$2.4 million in Q4 2025, and -$3.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn | -26.60 Mn |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn | -139.00 Mn |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn | -218.00 Mn |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn | -96.00 Mn |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn | -58.03 Mn |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn | -43.20 Mn |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn | -77.00 Mn |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn | -90.00 Mn |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn | -131.58 Mn |
| 10 | Sanara MedTech | 228.72 Mn | 215.13 Mn | 25.87 Mn | -43,772.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -43,772.00 |
| Mar 31, 2026 | -43,772.00 |
| Dec 31, 2025 | -2.45 Mn |
| Dec 31, 2025 | -2.45 Mn |
| Sep 30, 2025 | -3.42 Mn |
| Sep 30, 2025 | -3.42 Mn |
| Jun 30, 2025 | -3.93 Mn |
| Jun 30, 2025 | -3.93 Mn |
| Mar 31, 2025 | -5.18 Mn |
| Mar 31, 2025 | -5.18 Mn |
| Dec 31, 2024 | -129,994.00 |
| Dec 31, 2024 | -129,994.00 |
| Sep 30, 2024 | -6.36 Mn |
| Sep 30, 2024 | -6.36 Mn |
| Jun 30, 2024 | -58,762.00 |
| Jun 30, 2024 | -58,762.00 |
| Mar 31, 2024 | -65,818.00 |
| Mar 31, 2024 | -65,818.00 |
| Dec 31, 2023 | -54,276.00 |
| Dec 31, 2023 | -54,276.00 |